Press release
Peptide CDMO (Pharmaceutical) Market Exclusive Report on Current Trends and Future Insights
According to the latest market research report, the global peptide CDMO (pharmaceutical) market is valued at US$ 2028.60 million in 2021, and it is expected to reach US$ 4321.26 million by 2030, with a CAGR of 9.0% during the forecast period of 2022-2030. By region, Asia Pacific dominated the market with a market share of 42.4% in 2021.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/1202
Peptides are minuscule molecules of protein that contain fewer amino acids than proteins. In addressing unmet medical needs, peptide therapeutics play a crucial function. Several peptide medications for treating various diseases, including cancer, diabetes, osteoporosis, chronic pain, multiple sclerosis, and HIV infection, have reached the market. Due to its unique peptide therapeutic properties and promising potential for the contract API manufacturing industry, peptide CDMO is regarded as an emerging market.
Developing healthcare infrastructure, increasing medical applications of peptides, rising healthcare expenditures, emerging peptide design technologies, growing usage of peptides for drug development, rising R&D investments for peptide-based therapies, high prevalence of chronic diseases, and the use of bioinformatics and systematic biological approaches are anticipated to drive the peptide CDMO (pharmaceutical) market during the forecast period. The high prevalence of chronic and infectious diseases increases the demand for pharmaceuticals. As a result, pharmaceutical companies began to utilize peptides and CDMOs to alleviate the manufacturing burden. Due to their high specificity, tolerability, and convenience of production, peptides are used, and contract manufacturing services save time and improve production efficiency. Opportunities for business expansion in the peptide CDMO (pharmaceutical) market will likely increase during the forecast period.
On the other hand, costly CDMO services and the need for specialized expertise in peptide production are anticipated to impede the market's growth over the forecast period.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1202
Regionally, North America, followed by Europe, is projected to lead the peptide CDMO (pharmaceutical) market during the forecast period (2022-2030), owing to the well-developing CDMOs, availability of peptide synthesis technologies, and the surging demand for peptides and drugs to treat chronic conditions.
Key market players operating in the peptide CDMO (pharmaceutical) market include AmbioPharm, Auspep, Bachem, BCN Peptide, CPC Scientific, CBL- Chemical and Biopharmaceutical Laboratories, ScinoPharm, Olon, Belyntic, Ferring Pharma, Numaferm, Hybio Pharmaceutical, Provepharm life solutions, Enzene Biosciences, Ardena Holding, Stelis Biopharma, Piramal Pharma, Space Peptides PharmaceuticalCreative Peptides, CSBio, Corden Pharma, PolyPeptide, Hybio Pharmaceutical, Peptide Institute, Pepscan, Almac, Chinese Peptide, CreoSalus Inc, Vivitide, Senn Chemicals, Wuxi AppTec, among others.
Key developments in the market:
• In January 2022, CordenPharma collaborated with PeptiSystems, a Swedish-based developer of peptide and oligonucleotide therapeutic process development and manufacturing instruments, to reduce the footprint impact and improve the Process Mass Intensity (PMI) of peptide manufacturing processes.
• In December 2021, Pepscan extended its column purification technology with a mid-sized column packer. This technology significantly reduces purification time and provides optimal flexibility when synthesizing peptides.
• In September 2021, CEM Corporation and AmbioPharm, Inc. partnered to produce GMP peptides for the global market. The partnership will involve an exclusive1 use of CEM's large-scale microwave peptide synthesis technology to produce GMP peptides up to multi-kilogram quantities using proprietary scalable reactors. Also, it will enable rapid and efficient production of peptide new chemical entities (NCE's) using the latest technologies available.
• In July 2021, CordenPharma expanded its peptide manufacturing capacity in CordenPharma Colorado, their GMP API facility in Boulder, CO (US). CordenPharma Colorado is the largest worldwide peptide API producer leading the global peptide market.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1202
Market Segments
Global Peptide CDMO (Pharmaceutical) Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Preclinical / Clinical
• Commercial
Global Peptide CDMO (Pharmaceutical) Market, by Method Used, 2022-2030 (Value US$ Mn)
• Chemical Synthesis Method
• Non-Chemical Synthesis Method
Global Peptide CDMO (Pharmaceutical) Market, by By Applications, 2022-2030 (Value US$ Mn)
• Peptide Supplements
• Peptide Vaccines
• Peptides as Radio-Theranostic Agents
• Cell Penetrating Peptides (CPPs)
• Affinity Ligands
• Protein Mimics
Global Peptide CDMO (Pharmaceutical) Market, by Synthesis Types, 2022-2030 (Value US$ Mn)
• LPPS
• SPPS
• Mixed Phase
Global Peptide CDMO (Pharmaceutical) Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Peptide CDMO (Pharmaceutical) Market, by Country, 2022-2030 (Value US$ Mn)
• The U.S.
• Canada
Europe Peptide CDMO (Pharmaceutical) Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Peptide CDMO (Pharmaceutical) Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Peptide CDMO (Pharmaceutical) Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Peptide CDMO (Pharmaceutical) Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of the Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global peptide CDMO (pharmaceutical) market
To receive an industry overview and future trends of the peptide CDMO (pharmaceutical) market
To analyze the peptide CDMO (pharmaceutical) market drivers and challenges
To get information on the peptide CDMO (pharmaceutical) market size (Value US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the peptide CDMO (pharmaceutical) market industry
Get more information: @
https://www.insightaceanalytic.com/report/global-peptide-cdmo-pharmaceutical-market-/1202
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide CDMO (Pharmaceutical) Market Exclusive Report on Current Trends and Future Insights here
News-ID: 3878265 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Veterinary Infectious Disease Diagnostics Market Growth and Restrain Factors Ana …
"Veterinary Infectious Disease Diagnostics Market" in terms of revenue was estimated to be worth $2.06 billion in 2023 and is poised to reach $3.95 billion by 2031, growing at a CAGR of 8.69% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1488
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the veterinary infectious disease diagnostics market are:
• Rising rates of…
Teledermatology Market Exclusive Report on Current Trends and Future Insights
"Teledermatology Market" in terms of revenue was estimated to be worth $10.85 billion in 2023 and is poised to reach $55.17 billion by 2031, growing at a CAGR of 22.73% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1475
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Teledermatology market are:
• Rising prevalence of skin disorders
• Integration of AI and Machines…
Sugar Free Food And Beverage Market Study Analysis with Forecast to 2034
InsightAce Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Sugar Free Food and Beverage Market (By Product Type (Beverages, Dairy, Confectionery, Bakery, and Others) and Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Specialty Stores, Online Stores, and Others))- Market Outlook and Industry Analysis 2034"
The global sugar free food and beverage market is estimated to exhibit a CAGR of 3.5% during the forecast period.
Request For Free…
Smart Pill Technology Market is on an Upward Growth Curve
"Smart Pill Technology Market" in terms of revenue was estimated to be worth $4.22 billion in 2023 and is poised to reach $9.21 billion by 2031, growing at a CAGR of 10.55% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1485
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the smart pill technology market are:
• Technological Advancements
• increasing colon cancer rates
• Increasing elderly…
More Releases for CDMO
FDP CDMO Research: China FDP CDMO market size is projected to reach USD 1.33 bil …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Fraud Detection and Prevention (FDP) System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the…
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
